Trump

Concierge medicine: What health execs need to knowMore providers, and even some health plans, are getting in on the action with concierge medicine. Here’s how it works and how it could affect your business.
Opinion: Five key takeaways from Trump's budget proposalTrump’s proposal highlights the administration’s priorities and can give stakeholders insight into future policy change.
Top 10 states with the worst drug problemsWalletHub released a study comparing 50 states and the District in terms of 15 key metrics, ranging from arrest and overdose rates to opioid prescriptions and meth-lab incidents per capita.
Pharmacy Groups Warn Trump About Drug ImportsNACDS and APhA warn that letting Americans buy foreign drugs could be disastrous.
New FDA lead ushers in new eraScott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
ACA uncertainty impacts rate of insured: What health execs should knowA Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance.
Congress considering ‘invisible’ high-risk poolsOur policy analyst explains the concept of invisible high-risk pools, and explains how they might affect health reform.
Four reasons GOP ACA replacement failed without a voteWhat exactly did House representatives on both sides of the aisle dislike about the AHCA? Here’s a look at what MCOs should know.
Five things to know about Trump’s FDA lead pick GottliebOn March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.